A Conversation With California’s New Attorney General
By Jill Cowan,
New York Times
| 04. 28. 2021
On Friday, the former state lawmaker Rob Bonta officially became California’s attorney general, stepping into a role that has served as a launching pad for some of the state’s most powerful politicians.
Mr. Bonta was the last of three high-profile appointments by Gov. Gavin Newsom in what observers have described as the most significant reshuffling of Democratic power the state has experienced in years. That Mr. Newsom now has close allies in three of the state’s top posts is likely to pay dividends as he campaigns to keep his job in a recall election later this year.
But political calculus aside, the attorney general wields broad power to shape the state’s criminal justice agenda — a task that has taken on heightened urgency amid a reckoning over racism and police violence.
During his second full day on the job, I spoke with Mr. Bonta about his priorities. Our conversation has been edited and condensed.
Yesterday your office announced that you would release more gun violence data to researchers and the public. What else is on the agenda in the...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...